Metrics as of 10/14/2026, 07:34 PM (Berlin time), refresh in progress.
Trulieve Cannabis Stock
Trulieve Cannabis Corp.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- CEO
- Kimberly A. Rivers
- Employees
- 5,000
- Market cap
- $1.7 B
- IPO
- 25/09/2018
Trulieve Cannabis Corp. is a healthcare company operating within the Drug Manufacturers - Specialty & Generic industry. Headquartered in Tallahassee, Florida, the company was founded by Kim Rivers and Jason Pernell on September 17, 1940. The business engages in the cultivation, processing, manufacturing, and retail…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Trulieve Cannabis stock: price history
1D
-1.5%
1W
-7.6%
1M
-14.3%
6M
+48.0%
YTD
+14.6%
1Y
+21.9%
2Y
-17.3%
5Y
-62.0%
10Y
–
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~87% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Trulieve Cannabis
Analyst assessment of Trulieve Cannabis
PRICE TARGET LOW
US$15.00
CONSENSUS
US$15.00
MEDIAN
US$15.00
PRICE TARGET HIGH
US$15.00
0
STRONG BUY
1
BUY
0
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Buy
As of: 07/08/2026
Trulieve Cannabis stock metrics
P/E
-26.47
P/B
1.87
EV/EBITDA
6.48
RETURN ON EQUITY
-52.9%
NET MARGIN
-149.9%
DEBT/EQUITY
0.75
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
–
FLOAT SHARES
162,355,527
AVG. DAILY VOLUME (30D)
2,333,273
Insider transactions (SEC)
Rivers Kim A.
Rivers Kim A.
Rivers Kim A.
Rivers Kim A.
Rivers Kim A.
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.5%
Forums (Reddit)
Comparable stocks
Frequently asked questions about Trulieve Cannabis stock
What does Trulieve Cannabis do?
Trulieve Cannabis Corp. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in United States.
The CEO is Kimberly A. Rivers, the company employs around 5,000 people.
The IPO was on 25/09/2018; the stock trades on NYSE under the ticker TRLV.
What do analysts say about Trulieve Cannabis stock?
1 analysts rate the stock, the consensus is Buy (as of 07/08/2026).
The average price target is US$15.00, ranging from US$15.00 to US$15.00, with a median of US$15.00.
This is an external assessment, not a statement by Market Jury.
When does Trulieve Cannabis report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 87% stronger than usual.
Does Trulieve Cannabis pay a dividend?
No, Trulieve Cannabis currently does not pay a dividend.
Which stocks are comparable to Trulieve Cannabis?
Comparable stocks include Zoetis, Viatris, Lantheus Holdings, Amneal Pharmaceuticals, Indivior Pharmaceuticals, Eton Pharmaceuticals, Pacira BioSciences and Amphastar Pharmaceuticals.
How can I get Trulieve Cannabis stock analyzed?
Clicking "Analyze stock" lets five strategies assess Trulieve Cannabis against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.